Kevin Spencer

Overview

Best Publications

• A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A

  K. Spencer;V. Souter;N. Tul;R. Snijders

  775
  Citations

• Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.

  K. H. Nicolaides;K. Spencer;K. Avgidou;S. Faiola

  614
  Citations

• First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications

  Charas Y. T. Ong;Adolfo W. Liao;Kevin Spencer;Shama Munim

  523
  Citations

• Analytical Reviews in Clinical Biochemistry: The Estimation of Creatinine:

  Kevin Spencer

  497
  Citations

• Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience

  Kevin Spencer;Christine E. Spencer;Maureen Power;Carolynne Dawson

  458
  Citations

• One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies

  R Bindra;V Heath;A Liao;K Spencer

  390
  Citations

• First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics

  K O Kagan;D Wright;K Spencer;F S Molina

  367
  Citations

• Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery Doppler

  Kevin Spencer;Christina K. H. Yu;Nicholas J. Cowans;Chineze Otigbah

  343
  Citations

• Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

  Peter Benn;Antoni Borrell;Rossa W. K. Chiu;Howard Cuckle

  322
  Citations

• First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia

  K. Spencer;N. J. Cowans;I. Chefetz;J. Tal

  314
  Citations

• Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.

  Kevin Spencer;Nicholas J. Cowans;Kypros H. Nicolaides

  307
  Citations

• Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.

  Peter Benn;Antoni Borell;Rossa Chiu;Howard Cuckle

  268
  Citations

• One Stop Clinic for Assessment of Risk for Fetal Anomalies: A Report of the First Year of Prospective Screening for Chromosomal Anomalies in the First Trimester

  Kevin Spencer;Christine E. Spencer;Maureen Power;Andy Moakes

  246
  Citations

• Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.

  Simona Cicero;Renu Bindra;Georgios Rembouskos;Kevin Spencer

  237
  Citations

• Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β ‐hCG and PAPP‐A at 10–14 weeks of gestation

  Kevin Spencer;Adolfo W. J. Liao;Hara Skentou;Simona Cicero

  236
  Citations

• Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011

  Peter Benn;Antoni Borrell;Howard Cuckle;Lorraine Dugoff

  228
  Citations

• First-Trimester Biochemical Markers of Aneuploidy and the Prediction of Small-for-Gestational Age Fetuses

  K. Spencer;N. J. Cowans;K. Avgidou;F. Molina

  227
  Citations

• First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.

  Nicholas J. Cowans;Kevin Spencer

  227
  Citations

• Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.

  Spencer K;Coombes Ej;Mallard As;Ward Am

  219
  Citations

• Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.

  Kyriaki Avgidou;Aris Papageorghiou;Renu Bindra;Kevin Spencer

  209
  Citations